News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Sinclair Michael
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/03/2023 |
4
| Sinclair Michael (10% Owner) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Disposed/sold 27,450 shares
@ $20, valued at
$549k
Disposed/sold 22,720 shares
@ $20, valued at
$454.4k
Disposed/sold 40,000 shares
@ $20, valued at
$800k
Disposed/sold 100,000 options
@ $8, valued at
$800k
Disposed/sold 250,000 options
@ $7.25, valued at
$1.8M
Disposed/sold 75,000 options
@ $6, valued at
$450k
|
|
| 06/17/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/15/2020 |
4
| Sinclair Michael (10% Owner) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC.|
Txns:
| Granted 2,000 shares
@ $0 |
|
| 09/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/06/2019 |
4/A
| Sinclair Michael (10% Owner) has filed a Form 4 on OPIANT PHARMACEUTICALS, INC. |
| 02/28/2018 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 01/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/03/2015 |
4/A
| Sinclair Michael (Executive Chairman) has filed a Form 4 on Lightlake Therapeutics Inc.|
Txns:
| Sold 1,700 shares
@ $3.5, valued at
$6k
Granted 1,700 shares
@ $3.69, valued at
$6.3k
Granted 1,600 shares
@ $3.69, valued at
$5.9k
Granted 1,500 shares
@ $3.94, valued at
$5.9k
Granted 130,000 options to buy
@ $8, valued at
$1M
Granted 105,000 options
@ $10, valued at
$1.1M
Granted 50,000 options
@ $15, valued at
$750k
Granted 50,000 options
@ $20, valued at
$1M
Granted 75,000 options
@ $6, valued at
$450k
Granted 150,000 options
@ $5, valued at
$750k
Granted 100,000 options
@ $8, valued at
$800k
|
|
| 11/06/2015 |
4
| Sinclair Michael (Executive Chairman) has filed a Form 4 on Lightlake Therapeutics Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 20,000 shares
@ $0
Sold 1,700 shares
@ $3.5, valued at
$6k
Granted 1,700 shares
@ $3.69, valued at
$6.3k
Granted 1,600 shares
@ $3.69, valued at
$5.9k
Granted 1,500 shares
@ $3.94, valued at
$5.9k
Granted 130,000 options to buy
@ $8, valued at
$1M
Granted 105,000 options
@ $10, valued at
$1.1M
Granted 50,000 options
@ $15, valued at
$750k
Granted 50,000 options
@ $20, valued at
$1M
Granted 75,000 options
@ $6, valued at
$450k
|
|
| 01/25/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/31/2012 |
4
| Sinclair Michael (Director) has filed a Form 4 on Lightlake Therapeutics Inc.|
Txns:
| Granted 150,000 shares
@ $0.078, valued at
$11.7k
Granted 50,000 shares
@ $0.08, valued at
$4k
Granted 100,000 shares
@ $0.06, valued at
$6k
Granted 10,000 shares
@ $0.06, valued at
$600 |
|
| 05/31/2012 |
3
| Sinclair Michael (Director) has filed a Form 3 on Lightlake Therapeutics Inc. |
|
|